Furthermore, in white VAT and SAT, sulpiride decreased adipocyte expansion due to hypertrophy, and in the VAT prevented the expression loss of Prlr and insulin sensitivity markers Insr and Glut4, and decreased Hif1α (hypoxia marker) expression in obesity conditions. The gene discussed is SLC2A4; the disease is obesity disorder.